Off-Label Marketing Puts Novartis in Hot Water – Sold to Children and is a Carcinogen

Off-Label Marketing Puts Novartis in Hot Water By ROSE BOUBOUSHIAN (CN) – Novartis Pharmaceuticals must face claims that it promoted the use on infants of a drug that U.S. regulators have deemed harmful, a federal judge ruled. While working as a senior sales consultant for Basel, Switzerland-based Novartis in its dermatology and respiratory division, from…

Feds Accuse Novartis of Kickback Drug Scheme

      MANHATTAN (CN) – Novartis Pharmaceuticals cost Medicare and Medicaid tens of millions of dollars by paying kickbacks to pharmacies to switch transplant patients to one of its drugs instead of cheaper generics, federal prosecutors say. The United States unsealed a four-count complaint against Novartis on Tuesday, accusing it of unjust enrichment, False…

Pfizer can do no wrong, or at least not enough to get found guilty ( Off-guideline does not equate to off-label )

Suit Over Pfizer Lipitor Labels Gave Judge ‘Paine’ By ADAM KLASFELD BROOKLYN, N.Y. (CN) – A federal judge invoked Thomas Paine’s “Common Sense” in dismissing allegations that Pfizer illegally marketed its cholesterol-fighting drug Lipitor. In her fifth complaint against Pfizer under the False Claims Act, former employee Dr. Jesse Polansky faulted the pharmaceutical company for…